VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%
Wed, 12 Jun

VENUS REMEDIES has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

VENUS REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m93269186425.1%-7.3%
Other incomeRs m3538714.4%1036.2%
TurnoverRs m93569590229.7%-3.6%
ExpensesRs m83864383529.8%-0.4%
Gross profitRs m9447-61-227.8%-164.6%
DepreciationRs m6283830.0%34.1%
InterestRs m98940-100.0%-100.0%
Profit before taxRs m-62-125-105
TaxRs m32-6-1-103.3%
Profit after taxRs m-94-119-104
Gross profit margin%10.16.9-7.0
Effective tax rate%-50.94.41.0
Net profit margin%-10.0-17.2-11.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 7.3% on a year-on-year (YoY) basis. The expenses were down by 0.4% YoY during the same period.
  • The company's operating profit declined by 164.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.0% in 4QFY19 as against 10.1% in 4QFY18.
  • Depreciation charges increased by 34.1% and finance costs declined by 100.0% YoY, respectively.
  • Other income increased by 1036.2% YoY during the quarter.
  • Net profit for the quarter declined by 11.1% YoY. Net profit margins during the quarter declined from -10.0% in 4QFY18 to -11.6% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 25.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 29.8% QoQ during the same period.
  • The company's operating profit declined by 227.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.0% in 4QFY19 as against 6.9% in 3QFY18.
  • Net profit for the quarter increased by 12.7% QoQ, while net profit margins increased from -17.1% in 3QFY18 to -11.6% in 4QFY19.

To see how VENUS REMEDIES has performed over the last eight quarters, please visit here.

VENUS REMEDIES Share Price Performance

Over the last one year, VENUS REMEDIES share price has moved up from Rs 57.1 to Rs 27.4, registering a Loss of Rs 29.7 or around 52.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,132.3 (up 0.0%). Over the last one year it has moved down from 13,755.6 to 13,132.3, a gain of 623 points (down 4.5%).

Overall, the S&P BSE SENSEX is up 12.2% over the year.

Current Valuations

At the current price of Rs 27.4, the price to book value (P/BV) ratio of VENUS REMEDIES stands at 0.1 times.

Equitymaster requests your view! Post a comment on "VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%". Click here!

  

Related Views on News

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of VENUS REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of VENUS REMEDIES. Also includes updates on the valuation of VENUS REMEDIES.

VENUS REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 16.3% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, VENUS REMEDIES has posted a net profit of Rs 8 m (down 16.3% YoY). Sales on the other hand came in at Rs 809 m (down 10.6% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

VENUS REMEDIES SHARE PRICE


Oct 18, 2019 09:07 AM

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES 5-YR ANALYSIS

COMPARE VENUS REMEDIES WITH

MARKET STATS